Vanguard Group Inc. Cuts Position in The Cooper Companies, Inc. $COO

Vanguard Group Inc. trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.2% during the third quarter, Holdings Channel reports. The institutional investor owned 23,974,821 shares of the medical device company’s stock after selling 279,856 shares during the quarter. Vanguard Group Inc. owned about 0.12% of Cooper Companies worth $1,643,714,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in COO. Wealth Alliance LLC increased its position in shares of Cooper Companies by 4.2% in the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock valued at $301,000 after purchasing an additional 171 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of Cooper Companies by 0.8% during the 3rd quarter. Pacer Advisors Inc. now owns 23,079 shares of the medical device company’s stock worth $1,582,000 after purchasing an additional 182 shares during the last quarter. Citizens Financial Group Inc. RI grew its stake in shares of Cooper Companies by 2.7% during the third quarter. Citizens Financial Group Inc. RI now owns 7,181 shares of the medical device company’s stock worth $492,000 after purchasing an additional 192 shares in the last quarter. State of Michigan Retirement System increased its holdings in Cooper Companies by 0.4% in the second quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock valued at $3,867,000 after buying an additional 200 shares during the last quarter. Finally, New York Life Investment Management LLC increased its holdings in Cooper Companies by 0.7% in the second quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company’s stock valued at $2,136,000 after buying an additional 210 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on COO. Citigroup reaffirmed a “neutral” rating and set a $88.00 price objective (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. Wells Fargo & Company increased their price target on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research note on Friday, December 5th. The Goldman Sachs Group reissued a “sell” rating and set a $73.00 price objective on shares of Cooper Companies in a report on Friday, January 9th. Finally, Stifel Nicolaus set a $95.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Stock Up 0.5%

COO stock opened at $84.07 on Friday. The company has a market cap of $16.48 billion, a price-to-earnings ratio of 44.72, a price-to-earnings-growth ratio of 2.39 and a beta of 1.03. The company has a fifty day moving average price of $82.12 and a 200 day moving average price of $75.21. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $92.84.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the firm posted $1.04 EPS. Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insider Transactions at Cooper Companies

In related news, insider Holly R. Sheffield acquired 1,230 shares of Cooper Companies stock in a transaction on Tuesday, December 16th. The stock was purchased at an average cost of $80.75 per share, with a total value of $99,322.50. Following the purchase, the insider directly owned 39,052 shares in the company, valued at approximately $3,153,449. The trade was a 3.25% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Albert G. White III bought 10,000 shares of the stock in a transaction on Tuesday, December 16th. The stock was bought at an average price of $80.80 per share, for a total transaction of $808,000.00. Following the completion of the purchase, the chief executive officer directly owned 236,151 shares in the company, valued at approximately $19,081,000.80. The trade was a 4.42% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 16,014 shares of company stock worth $1,304,416 over the last three months. 1.98% of the stock is currently owned by company insiders.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.